BIOMAT Database Logo BIOMAT Database Logo

Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin. 1994

M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Laboratoire et Service d'Infectiologie, Université Laval, Ste-Foy, Québec, Canada.

The lipopeptidic antibiotic daptomycin is reported to reduce experimental tobramycin nephrotoxicity (D. Beauchamp, M. Pellerin, P. Gourde, M. Pettigrew and M. G. Bergeron, Antimicrob. Agents Chemother. 34:139-147, 1990; C. A. Wood, H. C. Finkbeiner, S. J. Kohlhepp, P. W. Kohnen, and D. C. Gilbert, Antimicrob. Agents Chemother. 33:1280-1285, 1989). In an attempt to explain these results, the in vivo and in vitro interactions between daptomycin and tobramycin were studied. Tobramycin alone and preincubated with negatively charged phospholipid bilayers (liposomes) was dialyzed against increasing concentrations of daptomycin in buffer at pH 5.4. A significant drop in the concentration of tobramycin was observed when daptomycin was added to the opposite half cells. Furthermore, daptomycin induced a concentration-dependent release of lipid-bound tobramycin. Gold labeling experiments showed that daptomycin could be incorporated into phospholipid layers. Female Sprague-Dawley rats were treated with daptomycin alone, with tobramycin alone, or with the combination over 2 to 10 days. Levels of daptomycin and tobramycin in serum were similar in all groups. The levels of tobramycin in the renal cortex increased significantly with time and, on day 10, reached values of 654 +/- 122 and 844 +/- 298 micrograms/g of tissue (mean +/- standard deviation; not significant) in animals treated with tobramycin and the combination of daptomycin-tobramycin, respectively. No significant difference was observed in the levels of tobramycin in the kidneys between animals treated with tobramycin or the daptomycin-tobramycin combination at any time. By contrast, daptomycin levels were significantly higher in the renal cortexes of animals treated with daptomycin-tobramycin in comparison with those in the renal cortexes of animals treated with daptomycin alone on days 6,8, and 10 (P < 0.01). For immunogold labeling studies, animals were killed 4 h after a single injection of daptomycin alone or daptomycin in combination with tobramycin. Daptomycin was found throughout the matrixes of the lysosomes of proximal tubular cells of animals treated with daptomycin alone. In animals treated with the combination of daptomycin and tobramycin, daptomycin was associated with intralysosomal myeloid bodies. Our results suggest that daptomycin might attenuate experimental aminoglycoside nephrotoxicity by interacting with the aminoglycoside, perhaps electrostatically, and thereby protecting intracellular targets of toxicity.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007672 Kidney Cortex The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. Cortex, Kidney
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D003956 Dialysis A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Dialyses
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013347 Subcellular Fractions Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p163) Fraction, Subcellular,Fractions, Subcellular,Subcellular Fraction

Related Publications

M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity.
August 1989, Antimicrobial agents and chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin.
June 1985, Antimicrobial agents and chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.
January 1990, Antimicrobial agents and chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity.
May 1994, Antimicrobial agents and chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Vancomycin enhancement of experimental tobramycin nephrotoxicity.
July 1986, Antimicrobial agents and chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Letter: Tobramycin/cephalothin nephrotoxicity.
March 1976, Lancet (London, England),
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Influence of dosage regimen on experimental tobramycin nephrotoxicity. A biochemical approach.
January 1983, Chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Ceftriaxone protects against tobramycin nephrotoxicity.
April 1994, Antimicrobial agents and chemotherapy,
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Nephrotoxicity with gentamicin or tobramycin.
September 1979, Lancet (London, England),
M Couture, and M Simard, and P Gourde, and C Lessard, and K Gurnani, and L Lin, and D Carrier, and M G Bergeron, and D Beauchamp
Nephrotoxicity with gentamicin or tobramycin.
January 1980, Lancet (London, England),
Copied contents to your clipboard!